Beaverton lab identifies drug that turns off key gene in deadly childhood muscle cancer
The Children's Cancer Therapy Development Institute is studying how a breast cancer drug candidate could impact children with an aggressive tumor in the soft muscle.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Elizabeth Hayes Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Cancer Therapy | Child Development | Childhood Cancer | Children | Genetics | Health Management